PACS Group, Inc. Jefferies Healthcare Services and Technology Conference
Review the key takeaways and the transcript of this earnings call.
- PACS Group operates skilled nursing facilities across the country and has grown from two facilities in 2014 to around 358.
- The company said it performed at a very high level in the first two quarters of '26, with continued execution on clinical performance.
- PACS Group runs just over 90% occupancy company-wide, while mature facilities operate at about 94% occupancy and 32% skilled mix.
- Same-store growth has been around 6% this year so far, and mature-business margins are more like a mid-teens kind of number versus approximately 11% overall.
- The same-store portfolio includes 284 facilities, of which 88 are ramping at about 87% occupancy and 27% skilled mix.
- PACS Group said its balance sheet has almost no leverage, at 0.1 times leverage.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Awesome. Good morning, and welcome to the 2026 Jefferies Healthcare Services Conference. I am Brian Tanquilut, healthcare services analyst here at Jefferies. Our next fireside chat is with PACS Group. They are one of the largest operators of skilled nursing facilities in the U.S. Joining us today are Jason, Josh, and Carey, the company's management team. Maybe I will start, Jason, if you can just give us a little bit of an overview on PACS and also the state of the union.
Yeah, sure, and thanks, Brian. Thanks, everyone. We are excited to be here. PACS is a post-acute healthcare services company. We operate skilled nursing facilities across the country, as was mentioned. Our business model is one where we target underperforming facilities that have not reached their full potential operationally. We have a leadership model and operational model that we deploy in those facilities. We work to turn the operations around and add value to those locations. We started in 2014. I am one of the co-founders of the company, along with my business partner, Mark Hancock. Started with two facilities back in 2014. We have grown today to around 350- 58 58.
We have done that, again, largely through the business thesis of taking underperforming and deploying a new operating model to them. The company as we look at this past year in 2026, or I should say in 2026, the first two quarters of 2026, we have been performing at a very high level. We continue to execute on the clinical side, which is key to our success as an organization. We like to think of ourselves as one of the best providers in our sector from a clinical standpoint. The metrics, I think, point to that. We believe strongly that everything that we do, all the success that we have been able to achieve at our facility level as an organization begins with quality care. As we take these underperforming facilities, typically they are broken in many ways.
Clinically, they, again, are not performing at the level that they should. As we invest in those facilities, deploy capital, and probably more importantly, deploy the leadership needed for those facilities to turn around, we start to see the clinical product improve and the clinical outcomes improve. That creates a virtuous cycle within the facilities where reimbursement improves, the occupancy levels improve, and the referral patterns improve. So it all begins with care and quality. That is something that we- It is a reputation that we are trying to build for ourselves. I think over the last several years, we have been able to accomplish that. That is a general overview of the company.
No, that's awesome. Maybe Carey. Carey's a good longtime friend of mine. When he joined PACS, I was pretty excited. I'll ask you the question, when you joined PACS, why PACS? The other thing is, as you think through the performance of the first half of the year versus what your outlook is for the back half of the year, if you can just walk us through how you expect that to progress.
Sure, you bet. First of all, why did I join PACS? Meeting Jason, his other co-founder, Mark Hancock, Josh, this team, they're an incredible group of people, high character, high integrity people. Looking at the operating model, that was so important to me, and I've been even more impressed after joining than I was in looking at it previous. This operating team is the finest operating team I've ever had the opportunity to be associated with. They know what drives results, and they focus on those things, and then they produce results. As a CFO, it's great to have that comfort to know that the operating team's going to come through, particularly when you're talking about guidance. You mentioned guidance. We've been really pleased with how the year has gone so far, as Jason mentioned.
We went into the year thinking we'd have about $565 million of EBITDA. That was the midpoint of our initial guidance. Our guidance has improved now to a midpoint of $650 million of EBITDA, so improved quite a bit. That means we've had a really strong first and second quarter, and we expect a good third and fourth quarter. We're about halfway to that 650 mark through the first two quarters of the year, a little less. So we expect a good second half of the year as well. So really pleased to be at PACS, an incredible group of people. My finance organization is a real high-quality organization as well. I'm just trying to make sure I build that finance organization to be able to scale with the growth of the business as we go forward.
Josh, maybe I'll turn to you. When Jason was describing the strategy and the model of acquiring relatively underperforming locations or facilities, walk us through what you bring to the table to turn these things around, and what are the KPIs that you track? What are the levers that you pull to drive that growth and the timeline to get an acquired facility to optimal operations?
Yeah. As mentioned, both for Jason and myself, we are nursing home administrators. That is our background. That is how we spent the early parts of our career. We understand what a good high-performing facility looks like and one that is underperforming. As he mentioned, our strategy has been, and really our mission has been to take the unfortunate reality that a lot of facilities are underperforming, both clinically and financially, and to be able to go in and to assess what we can do to make improvements. We generally start with assessing the leadership in the facility at the administrator position. The administrator hangs their license. They are responsible to run the day-to-day operations, and unfortunately in our space, we have not always attracted the best and the brightest, the most sophisticated operators.
For us, that was a heavy investment that we made early on, was teaching and training, recruiting what I would say is a non-typical nursing home administrator. Someone who is entrepreneurial, who is driven, who cares about the business, but understands that there are levers when you are running a business that you must pull in order to have great outcomes, and have those outcomes be great clinically and also financially. You mentioned KPIs for us. As we assess leaders, oftentimes, either refine the leader that is in place or make a replacement, and we have mentioned a number of times our Administrator in Training program, we think is the best in the business. We have about 50 AITs at this point.
That has grown over time with the growth, having a bench of talented individuals who are coming up, experiencing the day-to-day, understand what a good facility looks like, feels like, runs like, is important. We have plenty of resource to do that. As we look at these acquisitions, we are assessing that leadership, and then that leadership is assessing the team. Your director of nursing, your director of therapy, other key department managers who are leading people and processes in the facility are essential. That administrator, we believe, is capable to do those things. Decisions can stay as close to the patient as possible. When that happens, you start to see a buy-in.
You start to see people who are dedicated, and have access to what we offer at PACS, which is systems and technology and live information that they can view in the moment to see how they are performing clinically. What changes they can make, what they can do to train and educate their staff to take a more clinically complex patient, do it well, so that they can build a reputation in the community, where the people who are either contracting where their patients are going to go or actually referring patients to a facility are picking your facility to do that. We are tracking quality measures to ensure that we are providing excellent care. As Jason mentioned, that virtuous cycle is when that goes really well, that becomes noted in the community, and they start sending more patients and more clinically acute patients.
The KPIs we are usually measuring quality measures, then we are measuring occupancy, which we talked a lot about. How many heads are in the beds, and of those, how many of those are short-term, high acuity patients that generally reimburse higher but need an additional level and quality of care that is essential. We focus on those metrics. But when we talk about deploying into our model, it is assessing people and leadership, which has been foundational to how we have grown as an organization.
That is awesome. Jason, maybe as I think about, just broadly speaking, when we take it up to the 30,000 foot view, when we think through the SNF space, where does it stand today in terms of the regulatory environment and how regulators view the space? Because it has ebbed and flowed over the years, right? When you think of RUGs-III, RUGs-IV, right?
Sure. From back in the day.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
4 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
